Hana Pharm Co., Ltd.
KRX:293480.KS
11350 (KRW) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 53,498.278 | 57,066.025 | 57,378.448 | 55,605.844 | 57,362.832 | 54,109.727 | 54,496.357 | 54,525.066 | 51,098.08 | 50,725.489 | 53,626.78 | 49,725.861 | 48,553.282 | 44,500.648 | 48,644.629 | 45,092.646 | 41,802.664 | 41,765.565 | 43,956.637 | 41,533.983 | 41,065.469 | 39,790.91 | 40,993.93 | 37,528.521 | 38,452.022 | 35,858.301 | 38,667.256 |
| Cost of Revenue
| 18,894.083 | 21,507.966 | 21,659.131 | 21,301.356 | 21,128.844 | 20,121.921 | 20,270.598 | 21,319.45 | 19,319.072 | 18,695.9 | 18,167.883 | 16,327.762 | 16,543.429 | 14,549.598 | 17,760.809 | 16,133.05 | 14,716.279 | 14,672.489 | 15,757.772 | 13,755.139 | 13,674.579 | 12,962.293 | 14,417.23 | 12,320.516 | 12,643.708 | 11,544.424 | 13,702.76 |
| Gross Profit
| 34,604.195 | 35,558.059 | 35,719.317 | 34,304.488 | 36,233.988 | 33,987.806 | 34,225.759 | 33,205.616 | 31,779.008 | 32,029.589 | 35,458.897 | 33,398.1 | 32,009.853 | 29,951.05 | 30,883.82 | 28,959.596 | 27,086.385 | 27,093.076 | 28,198.865 | 27,778.844 | 27,390.891 | 26,828.617 | 26,576.7 | 25,208.005 | 25,808.314 | 24,313.877 | 24,964.496 |
| Gross Profit Ratio
| 0.647 | 0.623 | 0.623 | 0.617 | 0.632 | 0.628 | 0.628 | 0.609 | 0.622 | 0.631 | 0.661 | 0.672 | 0.659 | 0.673 | 0.635 | 0.642 | 0.648 | 0.649 | 0.642 | 0.669 | 0.667 | 0.674 | 0.648 | 0.672 | 0.671 | 0.678 | 0.646 |
| Reseach & Development Expenses
| 124,629.435 | 2,191.549 | 3,551.29 | 1,858.166 | 1,644.049 | 2,105.296 | 1,245.732 | 1,176.315 | 1,332.287 | 993.94 | 910.443 | 746.432 | 1,012.493 | 819.937 | 741.368 | 728.534 | 1,012.689 | 759.379 | 640.513 | 568.538 | 826.413 | 526.376 | 510.491 | 672.163 | 514.165 | 493.743 | 0 |
| General & Administrative Expenses
| 29,794.623 | 28,268.728 | 7,501.329 | 28,784.664 | 27,593.534 | 26,985.143 | 8,016.916 | 7,137.894 | 6,648.643 | 6,370.021 | 7,336.839 | 5,989.488 | 5,625.851 | 5,405.416 | 5,395.841 | 5,060.203 | 4,923.081 | 5,123.012 | 5,101.11 | 4,826.731 | 4,566.304 | 4,614.977 | 4,950.329 | 16,247.152 | 4,218.848 | 4,017.731 | 15,529.709 |
| Selling & Marketing Expenses
| -2,881.549 | -2,553.512 | 7,520.002 | 6,581.274 | 6,472.59 | 5,363.424 | 5,078.523 | 5,726.72 | 4,871.567 | 4,305.449 | 4,514.04 | 5,076.088 | 4,047.277 | 3,023.473 | 1,651.741 | 1,515.042 | 1,423.214 | 1,557.007 | 1,132.895 | 2,143.641 | 1,584.516 | 1,695.376 | 1,732.745 | 1,516.536 | 1,576.399 | 1,607.396 | 0 |
| SG&A
| 26,913.074 | 25,715.216 | 25,805.242 | 28,784.664 | 27,593.534 | 26,985.143 | 13,095.439 | 12,864.614 | 11,520.21 | 10,675.47 | 11,850.879 | 11,065.576 | 9,673.128 | 8,428.889 | 7,047.582 | 6,575.245 | 6,346.295 | 6,680.019 | 6,234.005 | 6,970.372 | 6,150.82 | 6,310.353 | 6,683.074 | 16,247.152 | 5,795.247 | 5,625.127 | 15,529.709 |
| Other Expenses
| -30.003 | -20.59 | -498.842 | -57,569.328 | -55,187.068 | -2,105.296 | 11,802.492 | 11,479.69 | 11,573.444 | 12,309.584 | -471.001 | 84.95 | -445.171 | 67.295 | -4,600.695 | 14.867 | -378.456 | 30.819 | 27.921 | -14.826 | -66.102 | -0.279 | 1,168.505 | -42.072 | -1,031.594 | -64.332 | -45.842 |
| Operating Expenses
| 151,572.512 | 27,927.355 | 29,855.374 | -28,784.664 | -27,593.534 | 26,985.143 | 26,143.663 | 25,520.619 | 24,425.941 | 23,978.994 | 23,988.354 | 25,176.533 | 21,375.942 | 24,267.011 | 22,073.537 | 19,465.915 | 20,700.969 | 20,107.366 | 19,161.907 | 18,624.542 | 19,842.944 | 19,001.244 | 17,738.329 | 16,247.152 | 17,376.911 | 16,983.907 | 15,529.709 |
| Operating Income
| -116,968.317 | 7,630.704 | 5,863.943 | 5,519.824 | 8,640.454 | 7,002.664 | 8,082.096 | 7,684.997 | 7,353.067 | 8,050.595 | 11,470.543 | 8,221.567 | 10,633.911 | 5,684.039 | 8,810.283 | 9,493.68 | 6,385.415 | 6,985.709 | 9,036.958 | 9,154.302 | 7,547.948 | 7,827.371 | 8,838.371 | 8,960.853 | 8,431.403 | 7,329.97 | 9,434.786 |
| Operating Income Ratio
| -2.186 | 0.134 | 0.102 | 0.099 | 0.151 | 0.129 | 0.148 | 0.141 | 0.144 | 0.159 | 0.214 | 0.165 | 0.219 | 0.128 | 0.181 | 0.211 | 0.153 | 0.167 | 0.206 | 0.22 | 0.184 | 0.197 | 0.216 | 0.239 | 0.219 | 0.204 | 0.244 |
| Total Other Income Expenses Net
| 122,636.921 | 277.951 | 1,116.227 | -488.531 | 356.327 | -103.952 | 122.625 | -469.413 | -180.275 | 74.659 | -12.411 | -545.667 | 106.003 | 205.839 | -3,817.379 | 86.303 | 277 | 274.36 | -171.147 | 472.387 | 351.576 | 642.183 | 390.525 | -48.373 | -1,271.362 | -301.64 | -291.615 |
| Income Before Tax
| 5,668.604 | 7,908.654 | 6,980.17 | 5,031.293 | 8,996.781 | 6,898.712 | 8,204.72 | 7,215.585 | 7,172.792 | 8,125.253 | 11,541.161 | 7,675.899 | 10,739.914 | 5,889.878 | 4,992.904 | 9,579.984 | 6,662.416 | 7,260.07 | 8,865.811 | 9,626.689 | 7,899.522 | 8,469.556 | 9,228.895 | 8,912.48 | 7,160.041 | 7,028.33 | 9,143.172 |
| Income Before Tax Ratio
| 0.106 | 0.139 | 0.122 | 0.09 | 0.157 | 0.127 | 0.151 | 0.132 | 0.14 | 0.16 | 0.215 | 0.154 | 0.221 | 0.132 | 0.103 | 0.212 | 0.159 | 0.174 | 0.202 | 0.232 | 0.192 | 0.213 | 0.225 | 0.237 | 0.186 | 0.196 | 0.236 |
| Income Tax Expense
| 637.15 | 1,833.636 | 1,494.631 | 1,206.062 | 1,285.849 | 1,587.645 | 1,325.927 | 1,747.506 | 1,309.038 | 2,028.701 | 4,443.925 | -68.377 | 2,028.267 | 1,429.201 | 9,172.497 | 1,267.814 | 1,464.709 | 1,697.488 | 1,989.186 | 2,046.354 | 796.362 | 1,725.953 | 1,310.281 | 2,103.311 | 1,272.795 | 1,476.477 | 1,864.001 |
| Net Income
| 5,031.454 | 6,075.019 | 5,485.539 | 3,825.231 | 7,710.933 | 5,311.067 | 6,878.793 | 5,468.079 | 5,863.755 | 6,096.552 | 7,097.235 | 7,744.276 | 8,711.647 | 4,460.677 | -4,179.594 | 8,312.171 | 5,197.707 | 5,562.582 | 6,876.626 | 7,580.335 | 7,103.161 | 6,743.603 | 7,918.614 | 6,809.17 | 5,887.246 | 5,551.852 | 7,281.412 |
| Net Income Ratio
| 0.094 | 0.106 | 0.096 | 0.069 | 0.134 | 0.098 | 0.126 | 0.1 | 0.115 | 0.12 | 0.132 | 0.156 | 0.179 | 0.1 | -0.086 | 0.184 | 0.124 | 0.133 | 0.156 | 0.183 | 0.173 | 0.169 | 0.193 | 0.181 | 0.153 | 0.155 | 0.188 |
| EPS
| 290.84 | 351.17 | 317.09 | 221.12 | 445.73 | 307.01 | 397.63 | 316.08 | 339 | 352.41 | 425.37 | 448 | 532 | 258.18 | -241.56 | 480 | 300 | 321.82 | 394.66 | 435.45 | 402.73 | 381.82 | 573.01 | 492.73 | 441.82 | 416.36 | 565.45 |
| EPS Diluted
| 290.84 | 351.17 | 317.09 | 221.12 | 445.73 | 307.01 | 397.63 | 316.08 | 338.96 | 352.41 | 425.37 | 448 | 532 | 258.18 | -241.56 | 480 | 300 | 321.82 | 394.66 | 435.45 | 402.73 | 381.82 | 573.01 | 492.73 | 441.82 | 416.36 | 565.45 |
| EBITDA
| -115,016.269 | 9,590.295 | 7,736.819 | 34,304.488 | 36,233.988 | 33,987.806 | 10,348.172 | 9,293.751 | 9,474.69 | 9,741.49 | 12,568.505 | 9,897.799 | 11,836.817 | 7,416.583 | 5,765.883 | 10,993.084 | 7,561.655 | 8,561.983 | 10,728.116 | 10,620.375 | 8,899.595 | 9,454.02 | 11,017.513 | 9,865.579 | 8,332.842 | 8,174.831 | 10,330.284 |
| EBITDA Ratio
| -2.15 | 0.168 | 0.135 | 0.617 | 0.632 | 0.628 | 0.19 | 0.17 | 0.185 | 0.192 | 0.234 | 0.199 | 0.244 | 0.167 | 0.119 | 0.244 | 0.181 | 0.205 | 0.244 | 0.256 | 0.217 | 0.238 | 0.269 | 0.263 | 0.217 | 0.228 | 0.267 |